| scholarly article | Q13442814 |
| P50 | author | Lauren Ancel Meyers | Q51905789 |
| Yanni Xiao | Q92526752 | ||
| Mingwang Shen | Q95993165 | ||
| P2093 | author name string | Libin Rong | |
| Steven E Bellan | |||
| P2860 | cites work | Emergence of drug resistance is associated with an increased risk of death among patients first starting HAART | Q21563427 |
| Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies | Q24597052 | ||
| Prevention of HIV-1 infection with early antiretroviral therapy | Q24634688 | ||
| Modelling HIV/AIDS epidemics in Botswana and India: impact of interventions to prevent transmission | Q24652196 | ||
| Transmitted drug resistance in persons with acute/early HIV-1 in San Francisco, 2002-2009 | Q28476489 | ||
| Sentinel surveillance of HIV-1 transmitted drug resistance, acute infection and recent infection | Q28477399 | ||
| Universal access to HIV treatment versus universal 'test and treat': transmission, drug resistance & treatment costs | Q28483485 | ||
| Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada | Q28537704 | ||
| Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model | Q29305377 | ||
| Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators | Q29547281 | ||
| Estimating population size, HIV prevalence and HIV incidence among men who have sex with men: a case example of synthesising multiple empirical data sources and methods in San Francisco. | Q30620002 | ||
| Estimating the Population Sizes of Men Who Have Sex With Men in US States and Counties Using Data From the American Community Survey. | Q31102262 | ||
| Predicting the transmission of drug-resistant HIV: comparing theory with data | Q33185562 | ||
| Using surveillance data to monitor entry into care of newly diagnosed HIV-infected persons: San Francisco, 2006-2007 | Q33399919 | ||
| ??? | Q27009249 | ||
| HIV prevalence, unrecognized infection, and HIV testing among men who have sex with men--five U.S. cities, June 2004-April 2005. | Q39721179 | ||
| Evolutionary dynamics of complex networks of HIV drug-resistant strains: the case of San Francisco | Q39909667 | ||
| Pre-exposure Prophylaxis (PrEP) Use, Seroadaptation, and Sexual Behavior Among Men Who Have Sex with Men, San Francisco, 2004-2014. | Q39914826 | ||
| Estimating Incidence of HIV Infection Among Men Who Have Sex with Men, San Francisco, 2004–2014. | Q40426615 | ||
| Projections of AIDS morbidity and mortality in San Francisco | Q41195519 | ||
| Life expectancy among HIV-positive patients in Rwanda: a retrospective observational cohort study | Q41377430 | ||
| Trends in the HIV Epidemic Among African American Men Who Have Sex with Men, San Francisco, 2004-2011. | Q41428633 | ||
| Global stability of an infection-age structured HIV-1 model linking within-host and between-host dynamics | Q41480633 | ||
| Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors. | Q42540769 | ||
| Minority quasispecies of drug-resistant HIV-1 that lead to early therapy failure in treatment-naive and -adherent patients | Q46195814 | ||
| Predicting the unpredictable: transmission of drug-resistant HIV. | Q46308728 | ||
| Prevalence of HIV infection and predictors of high-transmission sexual risk behaviors among men who have sex with men. | Q53693036 | ||
| How May Infection-Age-Dependent Infectivity Affect the Dynamics of HIV/AIDS? | Q56774003 | ||
| Antiretroviral drug resistance, HIV-1 tropism, and HIV-1 subtype among men who have sex with men with recent HIV-1 infection | Q57980503 | ||
| The estimated prevalence and incidence of HIV in 96 large US metropolitan areas | Q64134569 | ||
| The San Francisco Men's Health Study: III. Reduction in human immunodeficiency virus transmission among homosexual/bisexual men, 1982-86 | Q69331060 | ||
| The continuing HIV epidemic among men who have sex with men | Q73974814 | ||
| Risk for AIDS in multiethnic neighborhoods in San Francisco, California. The population-based AMEN Study | Q33606552 | ||
| Examining the promise of HIV elimination by 'test and treat' in hyperendemic settings | Q33780939 | ||
| A tale of two futures: HIV and antiretroviral therapy in San Francisco. | Q33887969 | ||
| HIV, transmitted drug resistance, and the paradox of preexposure prophylaxis | Q33982161 | ||
| Variation in HIV-1 set-point viral load: epidemiological analysis and an evolutionary hypothesis | Q34007753 | ||
| Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators. | Q34067875 | ||
| Improved virological outcomes in British Columbia concomitant with decreasing incidence of HIV type 1 drug resistance detection | Q34070640 | ||
| Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study | Q34126545 | ||
| Time trends in primary HIV-1 drug resistance among recently infected persons | Q34136709 | ||
| Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy. | Q34405742 | ||
| Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection | Q34485916 | ||
| A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa | Q34485938 | ||
| High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa | Q34629087 | ||
| Life expectancies of South African adults starting antiretroviral treatment: collaborative analysis of cohort studies | Q34667707 | ||
| The effect of expanded antiretroviral treatment strategies on the HIV epidemic among men who have sex with men in San Francisco | Q34756819 | ||
| Could widespread use of combination antiretroviral therapy eradicate HIV epidemics? | Q34768657 | ||
| What can modeling tell us about the threat of antiviral drug resistance? | Q35160729 | ||
| Reassessment of HIV-1 acute phase infectivity: accounting for heterogeneity and study design with simulated cohorts | Q35188056 | ||
| Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study | Q35316315 | ||
| The natural history of HIV-1 and HIV-2 infections in adults in Africa: a literature review | Q35882391 | ||
| HIV treatment as prevention and HPTN 052. | Q36364604 | ||
| A methodology for performing global uncertainty and sensitivity analysis in systems biology. | Q37197756 | ||
| Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis | Q37216235 | ||
| Increases in adult life expectancy in rural South Africa: valuing the scale-up of HIV treatment | Q37386000 | ||
| Routine surveillance for the detection of acute and recent HIV infections and transmission of antiretroviral resistance | Q37860956 | ||
| Averted HIV infections due to expanded antiretroviral treatment eligibility offsets risk of transmitted drug resistance: a modeling study | Q38864849 | ||
| Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda | Q38869763 | ||
| HIV-1 transmission, by stage of infection | Q38875941 | ||
| Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study | Q39043035 | ||
| A new trend in the HIV epidemic among men who have sex with men, San Francisco, 2004-2011. | Q39482151 | ||
| Antiretroviral drugs for tuberculosis control in the era of HIV/AIDS. | Q39594941 | ||
| Transmission fitness of drug-resistant human immunodeficiency virus and the prevalence of resistance in the antiretroviral-treated population | Q39642550 | ||
| The epidemiology of antiretroviral drug resistance among drug-naive HIV-1-infected persons in 10 US cities | Q39686664 | ||
| The prevalence of antiretroviral drug resistance in the United States | Q39687529 | ||
| P433 | issue | 1857 | |
| P921 | main subject | drug resistance | Q12147416 |
| anti-retroviral agent | Q50430310 | ||
| P577 | publication date | 2017-06-01 | |
| P1433 | published in | Proceedings of the Royal Society B | Q2625424 |
| P1476 | title | Early antiretroviral therapy and potent second-line drugs could decrease HIV incidence of drug resistance. | |
| P478 | volume | 284 |
| Q93235680 | A mathematical model for HIV prevention and control among men who have sex with men in China |
| Q89759514 | An activator of G protein-coupled receptor and MEK1/2-ERK1/2 signaling inhibits HIV-1 replication by altering viral RNA processing |
| Q47552775 | Cardiac glycoside/aglycones inhibit HIV-1 gene expression by a mechanism requiring MEK1/2-ERK1/2 signaling. |
| Q52567034 | The cost-effectiveness of oral HIV pre-exposure prophylaxis and early antiretroviral therapy in the presence of drug resistance among men who have sex with men in San Francisco. |
Search more.